Table 1.
Patients characteristics (N = 546)
| Demographics | |
|---|---|
| Age (Range, Mean, SD) | 23-62 (40.64, 6.21) |
| Employment | |
| Farmers | 5 |
| Craftspersons, shopkeepers, company managers | 28 |
| Executives and intellectual professions | 69 |
| Intermediate professions | 106 |
| Employees | 253 |
| Workers | 17 |
| Retired | 2 |
| Unemployed | 58 |
| Missing | 8 |
| Education | |
| No certificate | 34 |
| Secondary education diploma – below baccalaureate | 129 |
| Baccalaureate or equivalent diploma | 114 |
| First undergraduate cycle degree or equivalent diploma | 119 |
| Second university cycle degree, doctorate or equivalent diploma | 145 |
| Missing | 5 |
| Presence of child(ren) | 484 |
| Length of the relationship (in years): Mean (SD) | 13.71 (8.37) |
| Disease and treatments characteristics | |
| Event type | |
| First breast cancer | 517 |
| Local recurrence | 14 |
| Contralateral cancer | 13 |
| Missing | 2 |
| Time since diagnosis (in years): Mean (SD) | 2.47 (2.79) |
| Treatment for the current eventa | |
| Surgery | |
| Yes | 499 |
| No but planned | 42 |
| No | 5 |
| Partial mastectomy | 311 |
| Total mastectomy | 213 |
| Immediate reconstruction | 21 |
| Delayed reconstruction | 132 |
| Unwanted reconstruction | 17 |
| Unknown | 11 |
| sentinel lymph node biopsy | 160 |
| axillary lymph node dissection | 359 |
| Radiotherapy | |
| Yes | 343 |
| No but planned | 142 |
| No | 50 |
| Missing | 11 |
| Trastuzumab | |
| Yes | 134 |
| No but planned | 11 |
| No | 397 |
| Missing | 4 |
| Hormone therapy | |
| Yes | 251 |
| No but planned | 131 |
| No | 163 |
| Missing | 1 |
| Tamoxifen | 229 |
| Gonadotropin-Releasing Hormone (GnRH) | 29 |
| Aromatase inhibitors | 29 |
| Psychotherapy | |
| Yes | 74 |
| No | 466 |
| Missing | 6 |
| Antidepressants or anxiolytic drugs | |
| Yes | 148 |
| No | 394 |
| Missing | 4 |
| Sick leave | |
| Yes | 236 |
| No | 282 |
| Non applicable | 23 |
| Working part-time for medical reasons | |
| Yes | 28 |
| No | 481 |
| Non applicable | 29 |
| Missing | 8 |
aAll the patients were or had been undergoing chemotherapy at the time of the study